Hepion Pharmaceuticals's total assets for Q were $6.01M, a decrease of -62.41% from the previous quarter. HEPA total liabilities were $2.45M for the fiscal quarter, a -71.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.